The global market for Heparin Sodium API and Heparin Calcium API was estimated to be worth US$ 2635 million in 2023 and is forecast to a readjusted size of US$ 6149 million by 2030 with a CAGR of 12.6% during the forecast period 2024-2030

Heparin Sodium API and Heparin Calcium API - Market

Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.

The heparin market is primarily driven by its extensive use as an anticoagulant in various medical applications. Heparin plays a critical role in preventing blood clot formation and is widely used during surgeries, dialysis procedures, and in the treatment and prevention of deep vein thrombosis and pulmonary embolism. Additionally, the increasing prevalence of cardiovascular diseases and the growing aging population contribute to the rising demand for heparin. However, the market also faces challenges, including the complex manufacturing process of heparin from animal sources, such as pig intestines. Ensuring a stable and safe supply of heparin can be challenging, especially during outbreaks of animal diseases that may impact the availability of raw materials. Moreover, there have been instances of adulteration and contamination of heparin products in the past, necessitating stringent quality control and safety measures. To overcome these challenges, the industry is exploring alternative sources of heparin, such as synthetic and biosynthetic production methods, to reduce reliance on animal-derived heparin and enhance supply chain resilience. Collaborative efforts between regulatory bodies, manufacturers, and healthcare providers are essential to ensure the availability of safe and high-quality heparin and drive the growth of the heparin market while addressing concerns related to sourcing, production, and patient safety.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Heparin Sodium API and Heparin Calcium API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Heparin Sodium API and Heparin Calcium API by region & country, by Type, and by Application.

The Heparin Sodium API and Heparin Calcium API market size, estimations, and forecasts are provided in terms of sales volume (Billion Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heparin Sodium API and Heparin Calcium API.

Market Segmentation

Scope of Heparin Sodium API and Heparin Calcium API - Market Report

Report Metric	Details
Report Name	Heparin Sodium API and Heparin Calcium API - Market
Forecasted market size in 2030	US$ 6149 million
CAGR	12.6%
Forecasted years	2024 - 2030
Segment by Type:	Heparin Sodium Heparin Calcium
Segment by Application	UFH LMWH
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, Bioibérica, Qingdao Jiulong Biopharmaceutical, Changzhou Qianhong Biopharma, Dongying Tiandong Pharmaceutical, Opocrin, Hubei Enoray Biopharmaceutical, Yino Pharma, Cisen Pharmaceutical, Nanjing Xinbai Pharmaceutical, Sichuan Deebio Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Heparin Sodium API and Heparin Calcium API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Heparin Sodium API and Heparin Calcium API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Heparin Sodium API and Heparin Calcium API in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Heparin Sodium API and Heparin Calcium API - Market size in 2030?

Ans: The Heparin Sodium API and Heparin Calcium API - Market size in 2030 will be US$ 6149 million.

Who are the main players in the Heparin Sodium API and Heparin Calcium API - Market report?

Ans: The main players in the Heparin Sodium API and Heparin Calcium API - Market are Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, Bioibérica, Qingdao Jiulong Biopharmaceutical, Changzhou Qianhong Biopharma, Dongying Tiandong Pharmaceutical, Opocrin, Hubei Enoray Biopharmaceutical, Yino Pharma, Cisen Pharmaceutical, Nanjing Xinbai Pharmaceutical, Sichuan Deebio Pharmaceutical

What are the Application segmentation covered in the Heparin Sodium API and Heparin Calcium API - Market report?

Ans: The Applications covered in the Heparin Sodium API and Heparin Calcium API - Market report are UFH, LMWH

What are the Type segmentation covered in the Heparin Sodium API and Heparin Calcium API - Market report?

Ans: The Types covered in the Heparin Sodium API and Heparin Calcium API - Market report are Heparin Sodium, Heparin Calcium

1 Market Overview

1.1 Heparin Sodium API and Heparin Calcium API Product Introduction

1.2 Global Heparin Sodium API and Heparin Calcium API Market Size Forecast

1.2.1 Global Heparin Sodium API and Heparin Calcium API Sales Value (2019-2030)

1.2.2 Global Heparin Sodium API and Heparin Calcium API Sales Volume (2019-2030)

1.2.3 Global Heparin Sodium API and Heparin Calcium API Sales Price (2019-2030)

1.3 Heparin Sodium API and Heparin Calcium API Market Trends & Drivers

1.3.1 Heparin Sodium API and Heparin Calcium API Industry Trends

1.3.2 Heparin Sodium API and Heparin Calcium API Market Drivers & Opportunity

1.3.3 Heparin Sodium API and Heparin Calcium API Market Challenges

1.3.4 Heparin Sodium API and Heparin Calcium API Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Heparin Sodium API and Heparin Calcium API Players Revenue Ranking (2023)

2.2 Global Heparin Sodium API and Heparin Calcium API Revenue by Company (2019-2024)

2.3 Global Heparin Sodium API and Heparin Calcium API Players Sales Volume Ranking (2023)

2.4 Global Heparin Sodium API and Heparin Calcium API Sales Volume by Company Players (2019-2024)

2.5 Global Heparin Sodium API and Heparin Calcium API Average Price by Company (2019-2024)

2.6 Key Manufacturers Heparin Sodium API and Heparin Calcium API Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Heparin Sodium API and Heparin Calcium API Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Heparin Sodium API and Heparin Calcium API

2.9 Heparin Sodium API and Heparin Calcium API Market Competitive Analysis

2.9.1 Heparin Sodium API and Heparin Calcium API Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Heparin Sodium API and Heparin Calcium API Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin Sodium API and Heparin Calcium API as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Heparin Sodium

3.1.2 Heparin Calcium

3.2 Global Heparin Sodium API and Heparin Calcium API Sales Value by Type

3.2.1 Global Heparin Sodium API and Heparin Calcium API Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Heparin Sodium API and Heparin Calcium API Sales Value, by Type (2019-2030)

3.2.3 Global Heparin Sodium API and Heparin Calcium API Sales Value, by Type (%) (2019-2030)

3.3 Global Heparin Sodium API and Heparin Calcium API Sales Volume by Type

3.3.1 Global Heparin Sodium API and Heparin Calcium API Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Heparin Sodium API and Heparin Calcium API Sales Volume, by Type (2019-2030)

3.3.3 Global Heparin Sodium API and Heparin Calcium API Sales Volume, by Type (%) (2019-2030)

3.4 Global Heparin Sodium API and Heparin Calcium API Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 UFH

4.1.2 LMWH

4.2 Global Heparin Sodium API and Heparin Calcium API Sales Value by Application

4.2.1 Global Heparin Sodium API and Heparin Calcium API Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Heparin Sodium API and Heparin Calcium API Sales Value, by Application (2019-2030)

4.2.3 Global Heparin Sodium API and Heparin Calcium API Sales Value, by Application (%) (2019-2030)

4.3 Global Heparin Sodium API and Heparin Calcium API Sales Volume by Application

4.3.1 Global Heparin Sodium API and Heparin Calcium API Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Heparin Sodium API and Heparin Calcium API Sales Volume, by Application (2019-2030)

4.3.3 Global Heparin Sodium API and Heparin Calcium API Sales Volume, by Application (%) (2019-2030)

4.4 Global Heparin Sodium API and Heparin Calcium API Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Heparin Sodium API and Heparin Calcium API Sales Value by Region

5.1.1 Global Heparin Sodium API and Heparin Calcium API Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Heparin Sodium API and Heparin Calcium API Sales Value by Region (2019-2024)

5.1.3 Global Heparin Sodium API and Heparin Calcium API Sales Value by Region (2025-2030)

5.1.4 Global Heparin Sodium API and Heparin Calcium API Sales Value by Region (%), (2019-2030)

5.2 Global Heparin Sodium API and Heparin Calcium API Sales Volume by Region

5.2.1 Global Heparin Sodium API and Heparin Calcium API Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Heparin Sodium API and Heparin Calcium API Sales Volume by Region (2019-2024)

5.2.3 Global Heparin Sodium API and Heparin Calcium API Sales Volume by Region (2025-2030)

5.2.4 Global Heparin Sodium API and Heparin Calcium API Sales Volume by Region (%), (2019-2030)

5.3 Global Heparin Sodium API and Heparin Calcium API Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Heparin Sodium API and Heparin Calcium API Sales Value, 2019-2030

5.4.2 North America Heparin Sodium API and Heparin Calcium API Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Heparin Sodium API and Heparin Calcium API Sales Value, 2019-2030

5.5.2 Europe Heparin Sodium API and Heparin Calcium API Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Heparin Sodium API and Heparin Calcium API Sales Value, 2019-2030

5.6.2 Asia Pacific Heparin Sodium API and Heparin Calcium API Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Heparin Sodium API and Heparin Calcium API Sales Value, 2019-2030

5.7.2 South America Heparin Sodium API and Heparin Calcium API Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Heparin Sodium API and Heparin Calcium API Sales Value, 2019-2030

5.8.2 Middle East & Africa Heparin Sodium API and Heparin Calcium API Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Heparin Sodium API and Heparin Calcium API Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Heparin Sodium API and Heparin Calcium API Sales Value

6.2.1 Key Countries/Regions Heparin Sodium API and Heparin Calcium API Sales Value, 2019-2030

6.2.2 Key Countries/Regions Heparin Sodium API and Heparin Calcium API Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Heparin Sodium API and Heparin Calcium API Sales Value, 2019-2030

6.3.2 United States Heparin Sodium API and Heparin Calcium API Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Heparin Sodium API and Heparin Calcium API Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Heparin Sodium API and Heparin Calcium API Sales Value, 2019-2030

6.4.2 Europe Heparin Sodium API and Heparin Calcium API Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Heparin Sodium API and Heparin Calcium API Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Heparin Sodium API and Heparin Calcium API Sales Value, 2019-2030

6.5.2 China Heparin Sodium API and Heparin Calcium API Sales Value by Type (%), 2023 VS 2030

6.5.3 China Heparin Sodium API and Heparin Calcium API Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Heparin Sodium API and Heparin Calcium API Sales Value, 2019-2030

6.6.2 Japan Heparin Sodium API and Heparin Calcium API Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Heparin Sodium API and Heparin Calcium API Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Heparin Sodium API and Heparin Calcium API Sales Value, 2019-2030

6.7.2 South Korea Heparin Sodium API and Heparin Calcium API Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Heparin Sodium API and Heparin Calcium API Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Heparin Sodium API and Heparin Calcium API Sales Value, 2019-2030

6.8.2 Southeast Asia Heparin Sodium API and Heparin Calcium API Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Heparin Sodium API and Heparin Calcium API Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Heparin Sodium API and Heparin Calcium API Sales Value, 2019-2030

6.9.2 India Heparin Sodium API and Heparin Calcium API Sales Value by Type (%), 2023 VS 2030

6.9.3 India Heparin Sodium API and Heparin Calcium API Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Shenzhen Hepalink Pharmaceutical

7.1.1 Shenzhen Hepalink Pharmaceutical Company Information

7.1.2 Shenzhen Hepalink Pharmaceutical Introduction and Business Overview

7.1.3 Shenzhen Hepalink Pharmaceutical Heparin Sodium API and Heparin Calcium API Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Shenzhen Hepalink Pharmaceutical Heparin Sodium API and Heparin Calcium API Product Offerings

7.1.5 Shenzhen Hepalink Pharmaceutical Recent Development

7.2 Yantai Dongcheng Pharmaceutical

7.2.1 Yantai Dongcheng Pharmaceutical Company Information

7.2.2 Yantai Dongcheng Pharmaceutical Introduction and Business Overview

7.2.3 Yantai Dongcheng Pharmaceutical Heparin Sodium API and Heparin Calcium API Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Yantai Dongcheng Pharmaceutical Heparin Sodium API and Heparin Calcium API Product Offerings

7.2.5 Yantai Dongcheng Pharmaceutical Recent Development

7.3 Nanjing King-friend Biochemical Pharmaceutical

7.3.1 Nanjing King-friend Biochemical Pharmaceutical Company Information

7.3.2 Nanjing King-friend Biochemical Pharmaceutical Introduction and Business Overview

7.3.3 Nanjing King-friend Biochemical Pharmaceutical Heparin Sodium API and Heparin Calcium API Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Nanjing King-friend Biochemical Pharmaceutical Heparin Sodium API and Heparin Calcium API Product Offerings

7.3.5 Nanjing King-friend Biochemical Pharmaceutical Recent Development

7.4 Pfizer

7.4.1 Pfizer Company Information

7.4.2 Pfizer Introduction and Business Overview

7.4.3 Pfizer Heparin Sodium API and Heparin Calcium API Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Pfizer Heparin Sodium API and Heparin Calcium API Product Offerings

7.4.5 Pfizer Recent Development

7.5 Hebei Changshan Biochemical Pharmaceutical

7.5.1 Hebei Changshan Biochemical Pharmaceutical Company Information

7.5.2 Hebei Changshan Biochemical Pharmaceutical Introduction and Business Overview

7.5.3 Hebei Changshan Biochemical Pharmaceutical Heparin Sodium API and Heparin Calcium API Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Hebei Changshan Biochemical Pharmaceutical Heparin Sodium API and Heparin Calcium API Product Offerings

7.5.5 Hebei Changshan Biochemical Pharmaceutical Recent Development

7.6 Bioibérica

7.6.1 Bioibérica Company Information

7.6.2 Bioibérica Introduction and Business Overview

7.6.3 Bioibérica Heparin Sodium API and Heparin Calcium API Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Bioibérica Heparin Sodium API and Heparin Calcium API Product Offerings

7.6.5 Bioibérica Recent Development

7.7 Qingdao Jiulong Biopharmaceutical

7.7.1 Qingdao Jiulong Biopharmaceutical Company Information

7.7.2 Qingdao Jiulong Biopharmaceutical Introduction and Business Overview

7.7.3 Qingdao Jiulong Biopharmaceutical Heparin Sodium API and Heparin Calcium API Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Qingdao Jiulong Biopharmaceutical Heparin Sodium API and Heparin Calcium API Product Offerings

7.7.5 Qingdao Jiulong Biopharmaceutical Recent Development

7.8 Changzhou Qianhong Biopharma

7.8.1 Changzhou Qianhong Biopharma Company Information

7.8.2 Changzhou Qianhong Biopharma Introduction and Business Overview

7.8.3 Changzhou Qianhong Biopharma Heparin Sodium API and Heparin Calcium API Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Changzhou Qianhong Biopharma Heparin Sodium API and Heparin Calcium API Product Offerings

7.8.5 Changzhou Qianhong Biopharma Recent Development

7.9 Dongying Tiandong Pharmaceutical

7.9.1 Dongying Tiandong Pharmaceutical Company Information

7.9.2 Dongying Tiandong Pharmaceutical Introduction and Business Overview

7.9.3 Dongying Tiandong Pharmaceutical Heparin Sodium API and Heparin Calcium API Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Dongying Tiandong Pharmaceutical Heparin Sodium API and Heparin Calcium API Product Offerings

7.9.5 Dongying Tiandong Pharmaceutical Recent Development

7.10 Opocrin

7.10.1 Opocrin Company Information

7.10.2 Opocrin Introduction and Business Overview

7.10.3 Opocrin Heparin Sodium API and Heparin Calcium API Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Opocrin Heparin Sodium API and Heparin Calcium API Product Offerings

7.10.5 Opocrin Recent Development

7.11 Hubei Enoray Biopharmaceutical

7.11.1 Hubei Enoray Biopharmaceutical Company Information

7.11.2 Hubei Enoray Biopharmaceutical Introduction and Business Overview

7.11.3 Hubei Enoray Biopharmaceutical Heparin Sodium API and Heparin Calcium API Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Hubei Enoray Biopharmaceutical Heparin Sodium API and Heparin Calcium API Product Offerings

7.11.5 Hubei Enoray Biopharmaceutical Recent Development

7.12 Yino Pharma

7.12.1 Yino Pharma Company Information

7.12.2 Yino Pharma Introduction and Business Overview

7.12.3 Yino Pharma Heparin Sodium API and Heparin Calcium API Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Yino Pharma Heparin Sodium API and Heparin Calcium API Product Offerings

7.12.5 Yino Pharma Recent Development

7.13 Cisen Pharmaceutical

7.13.1 Cisen Pharmaceutical Company Information

7.13.2 Cisen Pharmaceutical Introduction and Business Overview

7.13.3 Cisen Pharmaceutical Heparin Sodium API and Heparin Calcium API Sales, Revenue and Gross Margin (2019-2024)

7.13.4 Cisen Pharmaceutical Heparin Sodium API and Heparin Calcium API Product Offerings

7.13.5 Cisen Pharmaceutical Recent Development

7.14 Nanjing Xinbai Pharmaceutical

7.14.1 Nanjing Xinbai Pharmaceutical Company Information

7.14.2 Nanjing Xinbai Pharmaceutical Introduction and Business Overview

7.14.3 Nanjing Xinbai Pharmaceutical Heparin Sodium API and Heparin Calcium API Sales, Revenue and Gross Margin (2019-2024)

7.14.4 Nanjing Xinbai Pharmaceutical Heparin Sodium API and Heparin Calcium API Product Offerings

7.14.5 Nanjing Xinbai Pharmaceutical Recent Development

7.15 Sichuan Deebio Pharmaceutical

7.15.1 Sichuan Deebio Pharmaceutical Company Information

7.15.2 Sichuan Deebio Pharmaceutical Introduction and Business Overview

7.15.3 Sichuan Deebio Pharmaceutical Heparin Sodium API and Heparin Calcium API Sales, Revenue and Gross Margin (2019-2024)

7.15.4 Sichuan Deebio Pharmaceutical Heparin Sodium API and Heparin Calcium API Product Offerings

7.15.5 Sichuan Deebio Pharmaceutical Recent Development

8 Industry Chain Analysis

8.1 Heparin Sodium API and Heparin Calcium API Industrial Chain

8.2 Heparin Sodium API and Heparin Calcium API Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Heparin Sodium API and Heparin Calcium API Sales Model

8.5.2 Sales Channel

8.5.3 Heparin Sodium API and Heparin Calcium API Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Shenzhen Hepalink Pharmaceutical

Yantai Dongcheng Pharmaceutical

Nanjing King-friend Biochemical Pharmaceutical

Pfizer Inc

Hebei Changshan Biochemical Pharmaceutical

Bioibérica

Qingdao Jiulong Biopharmaceutical

Changzhou Qianhong Biopharma

Dongying Tiandong Pharmaceutical

Opocrin

Hubei Enoray Biopharmaceutical

Yino Pharma

Cisen Pharmaceutical

Nanjing Xinbai Pharmaceutical

Sichuan Deebio Pharmaceutical

List of Tables

Table 1. Heparin Sodium API and Heparin Calcium API Market Trends

Table 2. Heparin Sodium API and Heparin Calcium API Market Drivers & Opportunity

Table 3. Heparin Sodium API and Heparin Calcium API Market Challenges

Table 4. Heparin Sodium API and Heparin Calcium API Market Restraints

Table 5. Global Heparin Sodium API and Heparin Calcium API Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Heparin Sodium API and Heparin Calcium API Revenue Market Share by Company (2019-2024)

Table 7. Global Heparin Sodium API and Heparin Calcium API Sales Volume by Company (2019-2024) & (Billion Units)

Table 8. Global Heparin Sodium API and Heparin Calcium API Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Heparin Sodium API and Heparin Calcium API Price by Company (2019-2024) & (US$/Billion Units)

Table 10. Key Manufacturers Heparin Sodium API and Heparin Calcium API Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Heparin Sodium API and Heparin Calcium API Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Heparin Sodium API and Heparin Calcium API

Table 13. Global Heparin Sodium API and Heparin Calcium API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin Sodium API and Heparin Calcium API as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Heparin Sodium API and Heparin Calcium API Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Heparin Sodium API and Heparin Calcium API Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Heparin Sodium API and Heparin Calcium API Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Heparin Sodium API and Heparin Calcium API Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Heparin Sodium API and Heparin Calcium API Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Heparin Sodium API and Heparin Calcium API Sales Volume by Type: 2019 VS 2023 VS 2030 (Billion Units)

Table 22. Global Heparin Sodium API and Heparin Calcium API Sales Volume by Type (2019-2024) & (Billion Units)

Table 23. Global Heparin Sodium API and Heparin Calcium API Sales Volume by Type (2025-2030) & (Billion Units)

Table 24. Global Heparin Sodium API and Heparin Calcium API Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Heparin Sodium API and Heparin Calcium API Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Heparin Sodium API and Heparin Calcium API Price by Type (2019-2024) & (US$/Billion Units)

Table 27. Global Heparin Sodium API and Heparin Calcium API Price by Type (2025-2030) & (US$/Billion Units)

Table 28. Global Heparin Sodium API and Heparin Calcium API Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Heparin Sodium API and Heparin Calcium API Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Heparin Sodium API and Heparin Calcium API Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Heparin Sodium API and Heparin Calcium API Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Heparin Sodium API and Heparin Calcium API Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Heparin Sodium API and Heparin Calcium API Sales Volume by Application: 2019 VS 2023 VS 2030 (Billion Units)

Table 34. Global Heparin Sodium API and Heparin Calcium API Sales Volume by Application (2019-2024) & (Billion Units)

Table 35. Global Heparin Sodium API and Heparin Calcium API Sales Volume by Application (2025-2030) & (Billion Units)

Table 36. Global Heparin Sodium API and Heparin Calcium API Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Heparin Sodium API and Heparin Calcium API Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Heparin Sodium API and Heparin Calcium API Price by Application (2019-2024) & (US$/Billion Units)

Table 39. Global Heparin Sodium API and Heparin Calcium API Price by Application (2025-2030) & (US$/Billion Units)

Table 40. Global Heparin Sodium API and Heparin Calcium API Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Heparin Sodium API and Heparin Calcium API Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Heparin Sodium API and Heparin Calcium API Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Heparin Sodium API and Heparin Calcium API Sales Value by Region (2019-2024) & (%)

Table 44. Global Heparin Sodium API and Heparin Calcium API Sales Value by Region (2025-2030) & (%)

Table 45. Global Heparin Sodium API and Heparin Calcium API Sales Volume by Region (Billion Units): 2019 VS 2023 VS 2030

Table 46. Global Heparin Sodium API and Heparin Calcium API Sales Volume by Region (2019-2024) & (Billion Units)

Table 47. Global Heparin Sodium API and Heparin Calcium API Sales Volume by Region (2025-2030) & (Billion Units)

Table 48. Global Heparin Sodium API and Heparin Calcium API Sales Volume by Region (2019-2024) & (%)

Table 49. Global Heparin Sodium API and Heparin Calcium API Sales Volume by Region (2025-2030) & (%)

Table 50. Global Heparin Sodium API and Heparin Calcium API Average Price by Region (2019-2024) & (US$/Billion Units)

Table 51. Global Heparin Sodium API and Heparin Calcium API Average Price by Region (2025-2030) & (US$/Billion Units)

Table 52. Key Countries/Regions Heparin Sodium API and Heparin Calcium API Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Heparin Sodium API and Heparin Calcium API Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Heparin Sodium API and Heparin Calcium API Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Heparin Sodium API and Heparin Calcium API Sales Volume, (2019-2024) & (Billion Units)

Table 56. Key Countries/Regions Heparin Sodium API and Heparin Calcium API Sales Volume, (2025-2030) & (Billion Units)

Table 57. Shenzhen Hepalink Pharmaceutical Company Information

Table 58. Shenzhen Hepalink Pharmaceutical Introduction and Business Overview

Table 59. Shenzhen Hepalink Pharmaceutical Heparin Sodium API and Heparin Calcium API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)

Table 60. Shenzhen Hepalink Pharmaceutical Heparin Sodium API and Heparin Calcium API Product Offerings

Table 61. Shenzhen Hepalink Pharmaceutical Recent Development

Table 62. Yantai Dongcheng Pharmaceutical Company Information

Table 63. Yantai Dongcheng Pharmaceutical Introduction and Business Overview

Table 64. Yantai Dongcheng Pharmaceutical Heparin Sodium API and Heparin Calcium API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)

Table 65. Yantai Dongcheng Pharmaceutical Heparin Sodium API and Heparin Calcium API Product Offerings

Table 66. Yantai Dongcheng Pharmaceutical Recent Development

Table 67. Nanjing King-friend Biochemical Pharmaceutical Company Information

Table 68. Nanjing King-friend Biochemical Pharmaceutical Introduction and Business Overview

Table 69. Nanjing King-friend Biochemical Pharmaceutical Heparin Sodium API and Heparin Calcium API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)

Table 70. Nanjing King-friend Biochemical Pharmaceutical Heparin Sodium API and Heparin Calcium API Product Offerings

Table 71. Nanjing King-friend Biochemical Pharmaceutical Recent Development

Table 72. Pfizer Company Information

Table 73. Pfizer Introduction and Business Overview

Table 74. Pfizer Heparin Sodium API and Heparin Calcium API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)

Table 75. Pfizer Heparin Sodium API and Heparin Calcium API Product Offerings

Table 76. Pfizer Recent Development

Table 77. Hebei Changshan Biochemical Pharmaceutical Company Information

Table 78. Hebei Changshan Biochemical Pharmaceutical Introduction and Business Overview

Table 79. Hebei Changshan Biochemical Pharmaceutical Heparin Sodium API and Heparin Calcium API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)

Table 80. Hebei Changshan Biochemical Pharmaceutical Heparin Sodium API and Heparin Calcium API Product Offerings

Table 81. Hebei Changshan Biochemical Pharmaceutical Recent Development

Table 82. Bioibérica Company Information

Table 83. Bioibérica Introduction and Business Overview

Table 84. Bioibérica Heparin Sodium API and Heparin Calcium API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)

Table 85. Bioibérica Heparin Sodium API and Heparin Calcium API Product Offerings

Table 86. Bioibérica Recent Development

Table 87. Qingdao Jiulong Biopharmaceutical Company Information

Table 88. Qingdao Jiulong Biopharmaceutical Introduction and Business Overview

Table 89. Qingdao Jiulong Biopharmaceutical Heparin Sodium API and Heparin Calcium API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)

Table 90. Qingdao Jiulong Biopharmaceutical Heparin Sodium API and Heparin Calcium API Product Offerings

Table 91. Qingdao Jiulong Biopharmaceutical Recent Development

Table 92. Changzhou Qianhong Biopharma Company Information

Table 93. Changzhou Qianhong Biopharma Introduction and Business Overview

Table 94. Changzhou Qianhong Biopharma Heparin Sodium API and Heparin Calcium API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)

Table 95. Changzhou Qianhong Biopharma Heparin Sodium API and Heparin Calcium API Product Offerings

Table 96. Changzhou Qianhong Biopharma Recent Development

Table 97. Dongying Tiandong Pharmaceutical Company Information

Table 98. Dongying Tiandong Pharmaceutical Introduction and Business Overview

Table 99. Dongying Tiandong Pharmaceutical Heparin Sodium API and Heparin Calcium API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)

Table 100. Dongying Tiandong Pharmaceutical Heparin Sodium API and Heparin Calcium API Product Offerings

Table 101. Dongying Tiandong Pharmaceutical Recent Development

Table 102. Opocrin Company Information

Table 103. Opocrin Introduction and Business Overview

Table 104. Opocrin Heparin Sodium API and Heparin Calcium API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)

Table 105. Opocrin Heparin Sodium API and Heparin Calcium API Product Offerings

Table 106. Opocrin Recent Development

Table 107. Hubei Enoray Biopharmaceutical Company Information

Table 108. Hubei Enoray Biopharmaceutical Introduction and Business Overview

Table 109. Hubei Enoray Biopharmaceutical Heparin Sodium API and Heparin Calcium API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)

Table 110. Hubei Enoray Biopharmaceutical Heparin Sodium API and Heparin Calcium API Product Offerings

Table 111. Hubei Enoray Biopharmaceutical Recent Development

Table 112. Yino Pharma Company Information

Table 113. Yino Pharma Introduction and Business Overview

Table 114. Yino Pharma Heparin Sodium API and Heparin Calcium API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)

Table 115. Yino Pharma Heparin Sodium API and Heparin Calcium API Product Offerings

Table 116. Yino Pharma Recent Development

Table 117. Cisen Pharmaceutical Company Information

Table 118. Cisen Pharmaceutical Introduction and Business Overview

Table 119. Cisen Pharmaceutical Heparin Sodium API and Heparin Calcium API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)

Table 120. Cisen Pharmaceutical Heparin Sodium API and Heparin Calcium API Product Offerings

Table 121. Cisen Pharmaceutical Recent Development

Table 122. Nanjing Xinbai Pharmaceutical Company Information

Table 123. Nanjing Xinbai Pharmaceutical Introduction and Business Overview

Table 124. Nanjing Xinbai Pharmaceutical Heparin Sodium API and Heparin Calcium API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)

Table 125. Nanjing Xinbai Pharmaceutical Heparin Sodium API and Heparin Calcium API Product Offerings

Table 126. Nanjing Xinbai Pharmaceutical Recent Development

Table 127. Sichuan Deebio Pharmaceutical Company Information

Table 128. Sichuan Deebio Pharmaceutical Introduction and Business Overview

Table 129. Sichuan Deebio Pharmaceutical Heparin Sodium API and Heparin Calcium API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2019-2024)

Table 130. Sichuan Deebio Pharmaceutical Heparin Sodium API and Heparin Calcium API Product Offerings

Table 131. Sichuan Deebio Pharmaceutical Recent Development

Table 132. Key Raw Materials Lists

Table 133. Raw Materials Key Suppliers Lists

Table 134. Heparin Sodium API and Heparin Calcium API Downstream Customers

Table 135. Heparin Sodium API and Heparin Calcium API Distributors List

Table 136. Research Programs/Design for This Report

Table 137. Key Data Information from Secondary Sources

Table 138. Key Data Information from Primary Sources

List of Figures

Figure 1. Heparin Sodium API and Heparin Calcium API Product Picture

Figure 2. Global Heparin Sodium API and Heparin Calcium API Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Heparin Sodium API and Heparin Calcium API Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Heparin Sodium API and Heparin Calcium API Sales Volume (2019-2030) & (Billion Units)

Figure 5. Global Heparin Sodium API and Heparin Calcium API Sales Price (2019-2030) & (US$/Billion Units)

Figure 6. Heparin Sodium API and Heparin Calcium API Report Years Considered

Figure 7. Global Heparin Sodium API and Heparin Calcium API Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Heparin Sodium API and Heparin Calcium API Players Sales Volume Ranking (2023) & (Billion Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Heparin Sodium API and Heparin Calcium API Revenue in 2023

Figure 10. Heparin Sodium API and Heparin Calcium API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Heparin Sodium Picture

Figure 12. Heparin Calcium Picture

Figure 13. Global Heparin Sodium API and Heparin Calcium API Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Heparin Sodium API and Heparin Calcium API Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Heparin Sodium API and Heparin Calcium API Sales Volume by Type (2019 VS 2023 VS 2030) & (Billion Units)

Figure 16. Global Heparin Sodium API and Heparin Calcium API Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Heparin Sodium API and Heparin Calcium API Price by Type (2019-2030) & (US$/Billion Units)

Figure 18. Product Picture of UFH

Figure 19. Product Picture of LMWH

Figure 20. Global Heparin Sodium API and Heparin Calcium API Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Heparin Sodium API and Heparin Calcium API Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Heparin Sodium API and Heparin Calcium API Sales Volume by Application (2019 VS 2023 VS 2030) & (Billion Units)

Figure 23. Global Heparin Sodium API and Heparin Calcium API Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Heparin Sodium API and Heparin Calcium API Price by Application (2019-2030) & (US$/Billion Units)

Figure 25. North America Heparin Sodium API and Heparin Calcium API Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Heparin Sodium API and Heparin Calcium API Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Heparin Sodium API and Heparin Calcium API Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Heparin Sodium API and Heparin Calcium API Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Heparin Sodium API and Heparin Calcium API Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Heparin Sodium API and Heparin Calcium API Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Heparin Sodium API and Heparin Calcium API Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Heparin Sodium API and Heparin Calcium API Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Heparin Sodium API and Heparin Calcium API Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Heparin Sodium API and Heparin Calcium API Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Heparin Sodium API and Heparin Calcium API Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Heparin Sodium API and Heparin Calcium API Sales Volume (%), (2019-2030)

Figure 37. United States Heparin Sodium API and Heparin Calcium API Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Heparin Sodium API and Heparin Calcium API Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Heparin Sodium API and Heparin Calcium API Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Heparin Sodium API and Heparin Calcium API Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Heparin Sodium API and Heparin Calcium API Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Heparin Sodium API and Heparin Calcium API Sales Value by Application (%), 2023 VS 2030

Figure 43. China Heparin Sodium API and Heparin Calcium API Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Heparin Sodium API and Heparin Calcium API Sales Value by Type (%), 2023 VS 2030

Figure 45. China Heparin Sodium API and Heparin Calcium API Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Heparin Sodium API and Heparin Calcium API Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Heparin Sodium API and Heparin Calcium API Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Heparin Sodium API and Heparin Calcium API Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Heparin Sodium API and Heparin Calcium API Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Heparin Sodium API and Heparin Calcium API Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Heparin Sodium API and Heparin Calcium API Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Heparin Sodium API and Heparin Calcium API Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Heparin Sodium API and Heparin Calcium API Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Heparin Sodium API and Heparin Calcium API Sales Value by Application (%), 2023 VS 2030

Figure 55. India Heparin Sodium API and Heparin Calcium API Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Heparin Sodium API and Heparin Calcium API Sales Value by Type (%), 2023 VS 2030

Figure 57. India Heparin Sodium API and Heparin Calcium API Sales Value by Application (%), 2023 VS 2030

Figure 58. Heparin Sodium API and Heparin Calcium API Industrial Chain

Figure 59. Heparin Sodium API and Heparin Calcium API Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions